0 CHECKOUT

Kuwait Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3499761
  • November 2015
  • Region: Kuwait
  • 85 pages
  • Business Monitor International
1 of 4

Kuwait's pharmaceutical sector will remain insulated from the impact of lower oil prices given the country's strong fiscal buffers. Risks to our outlook include increasing generic penetration as health insurance coverage increases.

Headline Expenditure Projections
- Pharmaceuticals: From KWD287mn (USD1.01bn) in 2014 to KWD300mn (USD1.01bn) in 2015;
+4.7% in local currency terms and +0.6% in US dollar terms. Forecast unchanged from Q415.

- Healthcare: From KWD1.53bn (USD5.38bn) in 2014 to KWD1.64bn (USD5.55bn) in 2015; +7.3% in local currency terms and +3.1% in US dollar terms. Forecast in line with Q415.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (Kuwait 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kuwait 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kuwait 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kuwait 2013-2019)

Industry Risk Reward Index

Middle East and Africa Risk/Reward Index - Q1 2016

Kuwait Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector

Epidemiology

Competitive Landscape

Domestic Pharmaceutical Sector
Table: Multinational Company Activity

Company Profile

Advanced Technology Company

Bader Sultan & Bros

Kuwait-Saudi Pharmaceutical Industries (KSP)

Safwan Trading And Contracting Company

Demographic Forecast
Table: Population Headline Indicators (Kuwait 1990-2025)
Table: Key Population Ratios (Kuwait 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kuwait 1990-2025)
Table: Population By Age Group (Kuwait 1990-2025)
Table: Population By Age Group % (Kuwait 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Advanced Technology Company
Bader Sultan & Bros
Kuwait-Saudi Pharmaceutical Industries (KSP)
Safwan Trading And Contracting Company

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S